Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bicara Therapeutics Inc. ...

    NASDAQ: BCAX · Real-Time Price · USD
    11.43
    0.10 (0.88%)
    At close: Aug 14, 2025, 3:59 PM
    11.41
    -0.17%
    Pre-market: Aug 15, 2025, 08:45 AM EDT

    Bicara Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 68K 62K 56K 41K 28K 15K 2K 2K n/a n/a
    Gross Profit
    		 -68K -62K -56K -41K -28K -15K -2K -2K n/a n/a
    Operating Income
    		 -121.07M -106.61M -82.39M -69.44M -58.34M -49.12M -39.89M -26.2M -16.67M -8.34M
    Interest Income
    		 18.71M 16.73M 14.58M 10.02M 6.88M 4.18M 1.31M 13K n/a n/a
    Pretax Income
    		 -102.36M -89.8M -67.81M -59.47M -64.84M -58.41M -51.98M -39.55M -16.7M -8.35M
    Net Income
    		 -102.67M -90.06M -68M -59.48M -64.84M -58.41M -51.98M -39.55M -16.7M -8.35M
    Selling & General & Admin
    		 26.19M 22.6M 18.77M 15.14M 12.97M 11.12M 9.28M 6.15M 3.56M 1.78M
    Research & Development
    		 45.25M 56.26M 63.62M 54.3M 45.37M 37.99M 30.61M 20.05M 13.11M 6.56M
    Other Expenses
    		 49.62M 27.76M n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 121.07M 106.61M 82.39M 69.44M 58.34M 49.12M 39.89M 26.2M 16.67M 8.34M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 121.07M 106.61M 82.39M 69.44M 58.34M 49.12M 39.89M 26.2M 16.67M 8.34M
    Income Tax Expense
    		 166K 114.5K 187K 6K 6K 5.5K 5K n/a n/a n/a
    Shares Outstanding (Basic)
    		 54.54M 54.46M 54.44M 54.41M 54.18M 54.18M 53.09M 54.41M 54.6M 54.6M
    Shares Outstanding (Diluted)
    		 54.54M 54.46M 54.44M 54.41M 54.18M 54.18M 53.09M 54.41M 54.62M 54.62M
    EPS (Basic)
    		 -1.88 -1.65 -1.24 -1.09 -1.19 -1.07 -0.95 -0.72 -0.3 -0.15
    EPS (Diluted)
    		 -1.88 -1.65 -1.24 -1.09 -1.19 -1.07 -0.95 -0.72 -0.3 -0.15
    EBITDA
    		 -121.04M -106.57M -82.33M -81.47M -70.39M -61.18M -51.96M -26.2M -16.67M -8.33M
    EBIT
    		 -111.38M -101.6M -82.39M -81.53M -70.43M -61.21M -51.98M -26.2M -16.67M -8.34M
    Depreciation & Amortization
    		 49K 62K 56K 55K 42K 30.5K 19K 5K 3K 1.5K

    Add to Watchlist